Vaxart, Inc.

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
MRNAModerna, Inc. 7.84%348.830.0%$6190.05m
NVAXNovavax, Inc. -3.17%203.2479.8%$835.18m
BNTXBioNTech SE 0.35%281.960.0%$757.04m
SNSSSunesis Pharmaceuticals, Inc. -4.84%10.610.7%$741.68m
NTLAIntellia Therapeutics, Inc. -6.88%137.712.3%$596.78m
AMGNAmgen, Inc. 1.22%247.721.3%$537.34m
BIIBBiogen, Inc. -0.29%325.401.7%$533.59m
VRTXVertex Pharmaceuticals, Inc. 2.29%200.501.9%$461.09m
REGNRegeneron Pharmaceuticals, Inc. -0.09%586.352.7%$443.78m
GILDGilead Sciences, Inc. 0.54%69.021.0%$385.04m
ILMNIllumina, Inc. 1.85%495.513.5%$273.43m
CRSPCRISPR Therapeutics AG -2.00%122.270.6%$201.32m
OCGNOcugen, Inc. -1.98%6.940.0%$158.32m
ALNYAlnylam Pharmaceuticals, Inc. 0.33%182.418.3%$129.23m
EXASEXACT Sciences Corp. -0.07%117.9518.1%$126.26m

Company Profile

Vaxart, Inc. operates as a clinical-stage biotechnology company, which engages in the development of oral recombinant vaccines. Its products include Influenza, Norovirus and Respiratory Syncytial Virus. The company was founded in 2004 and is headquartered in South San Francisco, CA.